Beispiel: Heart Attack

Suchen Sie in klinischen Studien nach: Medroxyprogesterone Acetate

Insgesamt 181 ergebnisse

NCT02340013

Abgeschlossen

Endometrial Shedding Prior to Ovulation Induction Pilot Study

Bedingungen: Infertility
NCT03395756

Abgeschlossen

Depot Medroxyprogesterone Acetate as Emergency Contraception

Bedingungen: Emergency Contraception; Contraception
NCT01143207

Abgeschlossen

PK of Depo SubQ Injected in the Upper Arm

Bedingungen: Contraception
NCT00830414

Abgeschlossen

Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal Women

Bedingungen: Healthy
NCT01296152

Abgeschlossen

Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women

Bedingungen: HIV-1 Infection
NCT01463202

Abgeschlossen

Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression

Bedingungen: Contraception; Postpartum Depression; Lactation
NCT01461824

Abgeschlossen

Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent Subjects

Bedingungen: Weight Gain; Disorder of Bone Density and Structure, Unspecified; Uterine Bleeding
NCT02412436

Abgeschlossen

PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB

Bedingungen: HIV-1 Infection; Tuberculosis
NCT02509767

Abgeschlossen

Depo Provera Self-Administration Study: Putting a Patient-Centered Practice to the Test at Planned Parenthood

Bedingungen: Contraception
NCT00563576

Abgeschlossen

Pilot Study of Femring Estrogen Supplementation During Depo-Provera Initiation

Bedingungen: Metrorrhagia
NCT02732418

Abgeschlossen

Lower Dose Depo Provera® Contraceptive Injection

Bedingungen: Contraception
NCT04710017

Rekrutierung

Tranexamic Acid and Depot-Medroxyprogesterone Acetate for Perimenopausal Irregular Uterine Bleeding

Bedingungen: Irregular Uterine Bleeding
NCT02335203

Unbekannter Status

The Effect of Neoadjuvant DMPA on Glandular Cellularity in Women Awaiting Hysterectomy

Bedingungen: Grade 1 Endometrial Endometrioid Adenocarcinoma; Grade 2 Endometrial Endometrioid Adenocarcinoma; Complex Atypical Endometrial Hyperplasia
NCT03675139

Rekrutierung

MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia

Bedingungen: Endometrial Hyperplasia Without Atypia
NCT01191203

Abgeschlossen

Randomized Control Trial Copper Intrauterine Device and Depo-medroxyprogesterone Acetate (DMPA) of HIV+ Women in Malawi

Bedingungen: HIV
NCT01019369

Abgeschlossen

Study of Self or Clinic Administration of DepoProvera

Bedingungen: Contraception
NCT01776203

Beendet

Study of a Progestin to Prevent Bleeding Associated With Initiation of Medical Menopause With GnRH Agonist

Bedingungen: Dysfunctional Uterine Bleeding
NCT00064025

Abgeschlossen

Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus

Bedingungen: Endometrial Adenocarcinoma; Endometrial Adenosquamous Carcinoma; Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation; Recurrent Uterine Corpus Carcinoma; Stage I Uterine Corpus Cancer; Stage II Uterine Corpus Cancer; Stage III Uterine Corpus Cancer; Stage IV Uterine Corpus Cancer
NCT03300960

Abgeschlossen

Usefulness of Medroxyprogesterone Acetate in Follicular Phase in Oocyte Donors. Undergoing Ovarian Stimulation

Bedingungen: Infertility
NCT02103764

Unbekannter Status

Efficacy of Cyclic DSG Compared With Cyclic MPA for the Treatment of Anovulatory DUB

Bedingungen: Dysfunctional Uterine Bleeding
NCT03309176

Abgeschlossen

"Stair Step Study"

Bedingungen: Ovulation Disorder
NCT03018249

Aktiv, nicht rekrutierend

Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer

Bedingungen: FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma; FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma; FIGO Grade 3 Endometrial Endometrioid Adenocarcinoma
NCT01791413

Abgeschlossen

Effect of Pre-operative Depo Medroxyprogesterone Acetate on Serum Anti-mullerian Hormone Level After Laparoscopic Ovarian Cystectomy of Endometriomas

Bedingungen: Endometriosis
NCT02449161

Rekrutierung

The Effect of Post Ablation Medroxyprogesterone Acetate on Endometrial Amenorrhea Rates

Bedingungen: Menorrhagia
NCT00360490

Abgeschlossen

Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)

Bedingungen: Menorrhagia